Markets:

Overview

News

Currencies

International

Treasuries

Dyne Therapeutics, Inc. - Common Stock (NQ:DYN)

17.95 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Dyne Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

January 03, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...

Via Benzinga

Topics Stocks

Why Is Pinstripes (PNST) Stock Down 12% Today? ↗

January 03, 2024

Pinstripes stock is sliding lower on Wednesday as shares of PNST give up some of the gains they saw during their public debut yesterday.

Via InvestorPlace

Why Is Flex (FLEX) Stock Moving Today? ↗

January 03, 2024

Flex stock is on the move Wednesday after the company completed its spinoff of Nextracker by distributing its stake to holders of its stock.

Via InvestorPlace

Why Is Trinity Place (TPHS) Stock Up 97% Today? ↗

January 03, 2024

Trinity Place stock is up on Wednesday as investors in TPHS react to a new forbearance agreement update with heavy trading of the shares.

Via InvestorPlace

Why Is Dyne Therapeutics (DYN) Stock Up 39% Today? ↗

January 03, 2024

Dyne Therapeutics stock is rising higher on Wednesday as investors in DYN react to positive clinical trial news from the company.

Via InvestorPlace

Why Shares of Dyne Therapeutics Fell This Week ↗

September 15, 2023

Insiders sold more than 15,000 shares of company stock on Tuesday.

Via The Motley Fool

Dyne Therapeutics: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Dyne Therapeutics ↗

March 03, 2023

Via Benzinga

Why Is Rare Muscle Disease-Focused Dyne Therapeutics Stock Soaring Today? ↗

January 03, 2024

Dyne Therapeutics Inc (NASDAQ: DYN) released initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its DELIVER trial of DYNE-251 in patients with...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 03, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 03, 2024

It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning!

Via InvestorPlace

3 of the Best Cheap Stocks Under $20 to Buy Now: November Edition ↗

November 13, 2023

After dropping to 52-week lows, the markets have been rallying, sending traders and investors are looking for cheap stocks under $20.

Via InvestorPlace

Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories" ↗

July 20, 2022

Via Benzinga

Acuity Brands, C3.ai And Other Big Stocks Moving Lower On Tuesday ↗

April 04, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Analyst Says This Small Cap Biotech Firm Has 'Very Valuable Therapeutic,' Upgrades Stock ↗

February 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023 ↗

February 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023 ↗

February 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023 ↗

January 26, 2023

Via Benzinga

$10 Million Bet On Dyne Therapeutics? Check Out These 4 Stocks Insiders Are Buying ↗

December 15, 2022

Although US stocks closed lower on Wednesday following Fed’s rate decision, there were a few notable insider trades.

Via Benzinga

REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday ↗

December 14, 2022

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 14, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

Dyne Therapeutics: Q3 Earnings Insights ↗

November 03, 2022

Dyne Therapeutics (NASDAQ:DYN) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:28 AM. Here's what investors need to know about the announcement.

Via Benzinga

Avidity Biosciences, Kronos Worldwide And Some Other Big Stocks Moving Lower On Tuesday ↗

September 27, 2022

U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday ↗

November 23, 2022

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...

Via Benzinga

Dyne Therapeutics: Q2 Earnings Insights ↗

August 04, 2022

Dyne Therapeutics (NASDAQ:DYN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022 ↗

July 20, 2022

Upgrades

Via Benzinga

Avidity Biosciences Or Dyne Therapeutics - Read On Raymond James' Rating Skew ↗

July 12, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗

July 12, 2022

Upgrades

Via Benzinga

Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday ↗

July 06, 2022

Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.